Clinical trial
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
NCT00094302
Study timeline
Study start (unknown)2006-08-01Date precision: month
Registry last updated2015-03-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
SpironolactoneDRUG · verified · RxNorm: spironolactone
PlaceboDRUG
Sponsors & collaborators
Carelon Researchlead sponsor
Mapped research locations
Saint PetersburgRussia14PhiladelphiaPennsylvania, United States6MontrealQuebec, Canada6MoscowRussia6BostonMassachusetts, United States3ChicagoIllinois, United States3Los AngelesCalifornia, United States3DallasTexas, United States3AtlantaGeorgia, United States3Washington D.C.District of Columbia, United States3Oklahoma CityOklahoma, United States3MemphisTennessee, United States3
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00094302 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.